The SOX13 antibody is a valuable tool in biomedical research, targeting the SOX13 protein encoded by the *SOX13* gene, a member of the SOX (SRY-related HMG-box) transcription factor family. SOX proteins are pivotal in regulating embryonic development, cell differentiation, and tissue homeostasis. Specifically, SOX13 belongs to the SOXD subgroup (alongside SOX5. SOX6. and SOX21) and is implicated in diverse developmental processes, including neural tube formation, pancreatic islet cell differentiation, and cardiac development. It also plays roles in immune regulation, particularly in T-cell function and thymocyte maturation.
In disease contexts, SOX13 has been linked to autoimmune disorders, cancers, and neurodevelopmental conditions. Notably, it is recognized as an autoantigen in type 1 diabetes and celiac disease, where anti-SOX13 autoantibodies serve as diagnostic markers. Dysregulated SOX13 expression has been observed in malignancies like colorectal and prostate cancers, suggesting potential roles in tumor progression or suppression depending on the cellular context.
SOX13 antibodies are widely used in techniques such as Western blotting, immunohistochemistry (IHC), immunofluorescence (IF), and ELISA to study protein expression, localization, and interactions. Researchers employ these antibodies to explore SOX13's regulatory mechanisms, including its interplay with Wnt/β-catenin signaling and chromatin remodeling complexes. Cross-reactivity with orthologs in model organisms (e.g., mice, rats) further enhances their utility in translational studies. Overall, SOX13 antibodies are critical for unraveling the protein's multifaceted roles in health and disease.